SEC 13F Intelligence

Foresite Capital Management IV, LLC / SNDX

Foresite Capital Management IV, LLC’s Syndax Pharmaceuticals Inc Position

Does Foresite Capital Management IV, LLC own Syndax Pharmaceuticals Inc (SNDX)? Not currently — the last reported position was 875.0K shares worth $17M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$17M
Q3 2024
Shares
875.0K
% of Portfolio
+11.01%
Quarters Held
9
position exited

Position History SNDX

Reported value by quarter
Q3 ’22: $17MQ3 ’22Q4 ’22: $22MQ1 ’23: $18MQ1 ’23Q2 ’23: $18MQ3 ’23: $13MQ3 ’23Q4 ’23: $19MQ1 ’24: $21MQ1 ’24Q2 ’24: $18MQ3 ’24: $17MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024875.0K$17M+11.01%
Q2 2024875.0K$18M+12.07%
Q1 2024875.0K$21M+10.52%
Q4 2023875.0K$19M+9.56%
Q3 2023875.0K$13M+7.06%
Q2 2023875.0K$18M+9.00%
Q1 2023875.0K$18M+9.59%
Q4 2022875.0K$22M+9.51%
Q3 2022690.0K$17M+5.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of SNDX.